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Raised blood pressure is the most fre-
quent and most important risk factor for 
cardiovascular diseases and kidney dis-
ease [1] and thus one of the most impor-
tant modifiable risk factors for morbidity 
and mortality in Germany and worldwide 
[2]. It is estimated that high blood pres-
sure leads to 9.4 million deaths per year 
worldwide [3] and is responsible for 54% 
of all strokes and 47% of ischemic heart 
disease [4]. The potential for prevention 
of high blood pressure is large, since life-
style-related factors such as lack of phys-
ical activity, unhealthy diet, overweight 
and stress all contribute considerably to 
the development of high blood pressure 
[5] and since high blood pressure can be 
successfully lowered with changes in life-
style and with medication. Small popula-
tion-wide changes in blood pressure can 
have large overall effects: a population-
wide reduction in systolic blood pressure 
(SBP) of 5 mmHg can lead to a popula-
tion-wide reduction in stroke mortality of 
14%, in coronary heart disease of 9% and 
in overall mortality of 7% [6, 7].
According to current guidelines hyper-
tension is defined as blood pressure that 
persistently reaches or exceeds 140 mmHg 
systolic or 90 mmHg diastolic [8, 9]. How-
ever, an increased risk of stroke and cor-
onary heart disease is detectable already 
at lower levels of 115 mmHg SBP and 
75 mmHg diastolic blood pressure (DBP) 
and this risk increases steadily with rising 
blood pressure [1]. Therefore, at the pop-
ulation level, hypertension is just the tip 
of the iceberg. In fact, in addition to the 
prevalence of hypertension, the preva-
lence of normal (but no longer optimal) 
blood pressure and high-normal blood 
pressure (classified together as prehyper-
tension in US guidelines) are also relevant. 
Although individual risk associated with 
prehypertension is lower than risk asso-
ciated with hypertension, the prevalence 
of prehypertension is so high within the 
population that it accounts for approxi-
mately half of the blood pressure-relat-
ed burden of disease [4]. In addition, the 
mean blood pressure of a population is an 
important indicator of its cardiovascular 
risk [1].
This report presents nationwide da-
ta on the distribution of blood pressure 
among 18- to 79-year-old adults in Ger-
many from the German Health Inter-
view and Examination Survey for Adults 
(“Studie zur Gesundheit Erwachsener in 
Deutschland”, DEGS), first wave, DEGS1 
2008–2011, and thereby updates previous 
data from the German National Health 
Interview and Examination Survey 1998 
(GNHIES98).
Methods
The German Health Interview and Exam-
ination Survey for Adults (DEGS) is part 
of the health monitoring system at the 
Robert Koch Institute (RKI). The concept 
and design of DEGS are described in de-
tail elsewhere [10, 11, 12, 13, 14]. The first 
wave (DEGS1) was conducted from 2008–
2011 and comprised interviews, examina-
tions and tests [15, 16]. The target popula-
tion comprises the residents of Germany 
aged 18–79 years. DEGS1 has a mixed de-
sign, which permits both cross-sectional 
and longitudinal analyses. For this pur-
pose, a random sample from local pop-
ulation registries was drawn to complete 
the participants from the German Na-
tional Health Interview and Examination 
Survey 1998 (GNHIES98), who re-partic-
ipated. A total of 8,152 persons participat-
ed, including 4,193 first-time participants 
(response rate 42%) and 3,959 revisiting 
participants of GNHIES98 (response rate 
62%). There were 7,238 persons who at-
tended one of the 180 examination cen-
tres, and 914 who were interviewed on-
ly. The net sample [11] permits represen-
tative cross-sectional analyses and trend 
statements for the age group from 18–79 
in comparison with GNHIES98 (n=7,988, 
including 7,116 seen in examination cen-
tres). Longitudinal analyses can be per-
formed with the data from revisiting par-
ticipants. The cross-sectional and longi-
tudinal analyses are conducted using a 
weighting factor, which corrects devia-
tions in the sample from the population 
structure (as of 31 Dec 2010) with respect 
to age, sex, region and nationality as well 
as type of municipality and education 
[11]. A special weighting factor was gener-
ated for the examination part of the study. 
The calculation of the weighting for for-
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mer participants in GNHIES98 also ac-
counted for the reparticipation probabil-
ity of GNHIES98 participants, based on 
a logistic regression model. A non-re-
sponse analysis and comparison of select-
ed indicators from census statistics indi-
cate a high level of representativity of the 
net sample for the residential population 
aged 18–79 in Germany [11]. In order to 
take into account both the weighting and 
the correlation of participants within one 
municipality, confidence intervals were 
determined using SPSS 20 procedures for 
complex samples.
Social status was determined using 
an index which includes information on 
school education and vocational training, 
occupational status and net household in-
come (weighted by household needs) per-
mitting classification into low, middle and 
high status groups [17].
Systolic, diastolic and mean arterial 
pressures as well as pulse rate were de-
termined using automatic blood pres-
sure monitors (Datascope Accutorr 
Plus), which were also used in the Ger-
man Health Interview and Examination 
Survey for Children and Adolescents 
(KiGGS). These devices use the oscillo-
metric technique and not the ausculta-
tory method used in GNHIES98. When 
measuring blood pressure with an oscil-
lometric device—as in auscultatory mea-
surement—a pressure cuff on the upper 
arm is inflated to a level above the expect-
ed systolic pressure. With the auscultato-
ry method the systolic and diastolic blood 
pressures are determined by well trained 
examiners by slowly releasing the pres-
sure and listening (auscultation) with a 
stethoscope for the first and last sounds 
(Korotkoff sounds) in the brachial artery. 
With the oscillometric method on the 
other hand, oscillations transmitted from 
the vascular wall to the pressure cuff are 
evaluated automatically by the device and 
the blood pressure readings are displayed. 
The device used in DEGS1 meets the cri-
teria of the Association for the Advance-
ment of Medical Instrumentation and 
the British Hypertension Society with re-
spect to its agreement with the gold stan-
dard of auscultatory measurement using 
a standard mercury sphygmomanometer 
[18, 19, 20, 21]. Measurements were made 
in accordance with a standardised proto-
col. Participants sat upright on a height-
adjustable chair with a backrest, the right 
forearm was resting on a table at the level 
of the heart, the elbow was slightly bent, 
the legs were not crossed and the feet were 
placed firmly on the floor. To determine 
the cuff size the circumference of the up-
per arm was measured half way between 
the acromion and the olecranon (highest 
point of the shoulder blade to the tip of 
the elbow). Three cuffs were used accord-
ing to the following rule: a small cuff (cuff 
bladder 10.5×23.9 cm) for an upper arm 
circumference of 21–27.9 cm, a medium 
cuff (cuff bladder 13.5×30.7 cm) for an 
upper arm circumference of 28–35.9 cm, 
and a large cuff (cuff bladder 17×38.6 cm) 
for an upper arm circumference of 36–
46 cm. A mark on the cuff was used to 
ensure that the cuff was correctly posi-
tioned over the brachial artery. Follow-
ing a 5-minute rest three measurements 
were taken at 3-minute intervals. There 
was no speaking while measurements 
were taken. Finally the participant was in-
formed of any findings and given the re-
sults. Observance of the standardised ex-
amination protocol was subject to regu-
lar quality control. Analyses of SBP and 
DBP are based on the mean of the second 
and third blood pressure measurements.
Participants were asked as part of the 
medical interview whether they had ev-
er been told by a doctor that they have 
high or elevated blood pressure. As part 
of the medication interview it was record-
ed whether participants were taking an-
tihypertensive medication. The inter-
view included all medication taken over 
the previous 7 days. Drugs were coded in 
accordance with the World Health Orga-
nization’s (WHO) Anatomic Therapeu-
tic Chemical Classification System (ATC 
code). Medications were recorded as be-
ing antihypertensive if their primary effect 
is to lower blood pressure: diuretics (ATC 
code C03), beta-blockers (C07), calcium 
channel blockers (C08), ACE inhibitors 
(C09) and antihypertensive drugs (C02). 
However, since the indication for taking 
these drugs may be other than hyperten-
sion, the antihypertensive medication was 
only used for defining hypertension if the 
participant had known hypertension.
The following definitions were used 
based on the DEGS blood pressure mea-
surements, information on antihyperten-
sive medication and previous diagnoses:
Hypertension: hypertensive blood 
pressure in DEGS1 (SBP ≥140 or DBP 
≥90 mmHg, using the means of the sec-
ond and third DEGS1 measurements) or 
intake of antihypertensive medication in 
the previous 7 days given that the person 
had known hypertension.
Known hypertension: hypertension ac-
cording to the above definition in people 
who reported that they had been told pre-





























































































SBP systolic blood pressure, DBP diastolic blood pressure.
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viously by a doctor that they have high or 
elevated blood pressure.
Hypertensive blood pressure with no 
previous diagnosis of hypertension: hy-
pertensive blood pressure in DEGS1 (SBP 
≥140 or DBP ≥90 mmHg, using the mean 
of the second and third DEGS1 measure-
ments) in participants who denied detec-
tion of high or elevated blood pressure by 
a doctor in the past. This category is in-
ternationally customary in epidemiologi-
cal studies [22, 23], but only partly fulfils 
the clinical definition of hypertension. It 
is not designated “undiagnosed hyperten-
sion” since measurements were taken on 1 
day only, in contrast to the requirements 
for a clinical diagnosis.
Results
In DEGS1 standardised blood pressure 
measurements were carried out in 7,096 
of the 7,116 18- to 79-year-old partici-
pants in the cross-sectional sample. The 
mean SBP in 18- to 79-year-old men was 
127.4 mmHg, while in 18- to 79-year-
old women it was 120.8 mmHg (total 
124.1 mmHg; . Tab. 1). The mean DBP 
in 18- to 79-year-old men was 75.3 mmHg, 
while in 18- to 79-year-old women it was 
71.2 mmHg (total 73.2 mmHg). In almost 
every decade of life men had higher mean 
blood pressure than women. This differ-
ence was most pronounced for SBP and at 
younger ages. Among women there was a 
marked rise in SBP with age. SBP in men 
and DBP in both men and women, how-
ever, first rose with age but then reached 
a plateau approximately in the sixth de-
cade (SBP in men), and then decreased 
again slightly (DBP in men and women).
Blood pressure was classif ied 
(. Tab. 2) in accordance with the classi-
fication of the European Society of Hy-
pertension, which has also been adopt-
ed by the German Hypertension Society 
(“Deutsche Hochdruckliga e. V.”). Ac-
cording to this, 13% of women and 18% 
of men had hypertensive blood pressure 
(SBP ≥140 mmHg or DBP ≥90 mmHg), 
but only 29% of men and 53% of wom-
en had optimal blood pressure (SBP 
<120 mmHg and DBP <80 mmHg). The 
differences between men and women 
were most pronounced in the young-
est age group of 18–29 year olds: among 
men 8% had hypertensive blood pressure 
and only 33% had optimal blood pressure, 
while among women less than 1% had hy-
pertensive blood pressure and over 76% 
had optimal blood pressure.
The prevalence of hypertension ob-
served in this analysis, however, relates 
not only to hypertensive blood pressure 
on examination, but also includes hyper-
tension controlled by medication. Thus 
the prevalence of hypertension in the en-
tire sample of 18–79 year olds was 32% 
and was not substantially different in 
men and women (women 30%, men 33% 
with overlapping confidence intervals, 
. Tab. 3). A distinct rise with age could 
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Abstract
High blood pressure is one of the most im-
portant risk factors for cardiovascular dis-
eases and chronic kidney disease. It is a 
main determinant of morbidity and mor-
tality in Germany. In the German Health In-
terview and Examination Survey for Adults 
(DEGS1) the blood pressure of 7,096 adults 
aged 18–79 years was measured in a stan-
dardised way using oscillometric blood pres-
sure devices (Datascope Accutorr Plus). The 
average of the second and third measure-
ments was used for analysis. The mean systol-
ic blood pressure was 120.8 mmHg in wom-
en and 127.4 mmHg in men, while the mean 
diastolic blood pressure was 71.2 mmHg in 
women and 75.3 mmHg in men. Blood pres-
sure values were hypertensive (systolic blood 
pressure ≥140 mmHg or diastolic blood pres-
sure ≥90 mmHg) in 12.7% of women and in 
18.1% of men. Hypertension (defined as hav-
ing hypertensive blood pressure or taking 
antihypertensive medication in known cas-
es of hypertension) was present in 29.9% of 
women and 33.3% of men. Almost 75% of 
the survey’s highest age group, 70–79, had 
hypertension. DEGS1 demonstrates that 
high blood pressure remains a highly preva-
lent risk factor in the population at large. The 
methodology employed in measuring blood 
pressure has been improved as compared to 
that of the German National Health Interview 
and Examination Survey 1998 (GNHIES98) 
and it will be possible to draw comparisons 
soon, once a procedure for calibrating the 
1998 data has been finalised.
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Blutdruck in Deutschland 2008–2011. Ergebnisse der Studie 
zur Gesundheit Erwachsener in Deutschland (DEGS1)
Zusammenfassung
Hoher Blutdruck gehört zu den wichtigsten 
Risikofaktoren für Herz-Kreislauf-Krankheiten 
und chronische Niereninsuffizienz. Er ist eine 
wesentliche Determinante für Morbidität 
und Mortalität in Deutschland. Im Rahmen 
der bundesweiten Studie zur Gesundheit Er-
wachsener in Deutschland DEGS1 wurde 
bei 7096 Erwachsenen im Alter von 18 bis 
79 Jahren der Blutdruck standardisiert mit ei-
nem oszillometrischen Blutdruckmessgerät 
(Datascope Accutorr Plus) gemessen und der 
Durchschnitt der zweiten und dritten Mes-
sung ausgewertet. Der mittlere Blutdruck be-
trug systolisch bei Frauen 120,8 mmHg, bei 
Männern 127,4 mmHg, diastolisch bei Frauen 
71,2 mmHg, bei Männern 75,3 mmHg. Die 
Blutdruckwerte waren hyperton (systoli-
scher Blutdruck ≥140 mmHg oder diastolisch 
≥90 mmHg) bei 12,7% der Frauen und 18,1% 
der Männer. Eine Hypertonie (definiert als 
hypertoner Messwert oder Einnahme anti-
hypertensiver Medikamente bei bekannter 
Hypertonie) lag bei 29,9% der Frauen und 
33,3% der Männer vor. In der höchsten un-
tersuchten Altersgruppe der 70- bis 79-Jähri-
gen hatten fast 75% eine Hypertonie. DEGS1 
zeigt, dass Bluthochdruck nach wie vor ein 
weit verbreiteter Risikofaktor in der Bevölke-
rung ist. Die Methodik der Blutdruckmessung 
ist im Vergleich zu der im Bundes-Gesund-
heitssurvey 1998 verbessert worden, sodass 
Vergleiche erst in Kürze, nach Fertigstellung 
eines Kalibrierungsverfahrens der Daten von 
1998, möglich sein werden.
Schlüsselwörter
Gesundheitssurvey · Blutdruck · Hypertonie · 
Bluthochdruck · Prävalenz
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be observed in 18–50 year olds, with the 
prevalence of hypertension almost dou-
bling every 10 years and doubling again 
over the next 20 years, such that among 
70–79 year olds the prevalence was over 
70%. Prevalence-related differences in so-
cial status were evident among women, as 
women with high social status had a prev-
alence of hypertension only half that of 
women with low social status (. Tab. 3). 
Among men the prevalence of hyperten-
sion did not vary with social status.
Hypertension was subdivided in-
to known hypertension and hyperten-
sive blood pressure in DEGS1 without 
reported detection of high or elevated 
blood pressure by a doctor in the past 
(. Tab. 4). Overall, hypertension was al-
Tab. 2 Blood pressure in adults in Germany (prevalence and 95% CI), DEGS1, nunweighted=7,096
Age group 18–29 30–39 40–49 50–59 60–69 70–79 18–79
Men
Optimal 32.6 (28.5–36.9) 34.7 (29.3–40.6) 29.1 (24.8–33.9) 21.6 (18.2–25.4) 27.7 (23.2–32.7) 27.1 (22.4–32.3) 28.8 (26.8–31.0)
Normal 36.6 (32.0–41.5) 34.4 (29.1–40.2) 29.5 (25.0–34.4) 26.9 (23.1–31.0) 25.6 (21.7–29.8) 22.5 (18.0–27.7) 29.8 (27.8–31.8)
High normal 22.7 (18.6–27.5) 23.7 (18.8–29.4) 21.5 (17.7–25.9) 28.2 (23.7–33.0) 22.9 (18.9–27.6) 19.8 (16.1–24.1) 23.3 (21.5–25.2)
Hypertensive 8.1 (5.6–11.5) 7.2 (4.6–11.0) 19.9 (16.1–24.3) 23.4 (19.8–27.4) 23.8 (19.4–28.8) 30.7 (25.6–36.3) 18.1 (16.2–20.2)
Stage 1 7.9 (5.5–11.4) 7.2 (4.6–11.0) 17.5 (13.8–21.9) 19.1 (15.9–22.9) 19.4 (15.6–23.9) 27.0 (22.1–32.6) 15.8 (14.0–17.7)
Stage 2 or 3 0.2 (0.0–0.7) 0.0 (0.0–0.0) 2.4 (1.4–4.1) 4.3 (2.6–6.9) 4.4 (2.9–6.6) 3.6 (2.1–6.3) 2.4 (1.8–3.0)
Women
Optimal 75.9 (71.3–80.0) 74.3 (68.9–79.0) 61.0 (56.1–65.7) 42.8 (37.7–48.0) 32.9 (27.9–38.4) 22.9 (18.5–28.0) 53.0 (50.7–55.2)
Normal 19.2 (15.4–23.5) 17.1 (13.3–21.8) 21.1 (17.5–25.2) 23.1 (19.4–27.2) 22.8 (18.6–27.6) 23.9 (19.9–28.3) 21.1 (19.6–22.8)
High normal 4.0 (2.4–6.5) 6.3 (4.2–9.5) 9.7 (7.4–12.5) 18.8 (15.1–23.2) 22.6 (18.6–27.1) 20.5 (16.5–25.1) 13.2 (11.9–14.6)
Hypertensive 0.9 (0.4–2.1) 2.3 (1.0–5.2) 8.2 (6.1–11.0) 15.3 (12.5–18.7) 21.7 (17.8–26.3) 32.8 (28.1–37.7) 12.7 (11.3–14.3)
Stage 1 0.8 (0.3–1.9) 2.0 (0.9–4.5) 6.9 (5.0–9.6) 13.6 (10.9–16.9) 18.7 (15.2–22.9) 27.4 (23.2–32.1) 10.9 (9.5–12.3)
Stage 2 or 3 0.1 (0.0–1.0) 0.3 (0.0–2.1) 1.3 (0.6–2.8) 1.7 (0.9–3.2) 3.0 (1.5–6.0) 5.4 (3.4–8.4) 1.8 (1.3–2.5)
Total
Optimal 53.8 (50.4–57.2) 54.1 (49.7–58.5) 44.7 (41.3–48.2) 32.2 (29.0–35.6) 30.4 (26.8–34.2) 24.8 (21.4–28.6) 41.0 (39.3–42.7)
Normal 28.1 (24.9–31.4) 25.9 (22.5–29.7) 25.4 (22.4–28.5) 25.0 (22.2–28.0) 24.1 (21.3–27.3) 23.2 (20.1–26.7) 25.4 (24.2–26.7)
High normal 13.6 (11.3–16.2) 15.2 (12.3–18.6) 15.7 (13.4–18.3) 23.5 (20.6–26.7) 22.8 (19.8–26.0) 20.2 (17.4–23.2) 18.2 (17.1–19.4)
Hypertensive 4.6 (3.3–6.4) 4.8 (3.3–7.0) 14.2 (11.8–17.0) 19.4 (16.8–22.2) 22.7 (19.6–26.2) 31.8 (28.2–35.7) 15.4 (14.1–16.8)
Stage 1 4.4 (3.1–6.2) 4.6 (3.2–6.7) 12.3 (10.0–15.1) 16.4 (14.1–18.9) 19.1 (16.4–22.0) 27.2 (23.8–31.0) 13.3 (12.1–14.6)
Stage 2 or 3 0.2 (0.0–0.5) 0.1 (0.0–1.1) 1.9 (1.2–2.9) 3.0 (2.0–4.4) 3.7 (2.5–5.4) 4.6 (3.2–6.5) 2.1 (1.7–2.6)
Blood pressure classification in mmHg: optimal systolic blood pressure SBP <120 and diastolic blood pressure DBP <80, normal SBP 120–129 or DBP 80–84, high normal 
SBP 130–139 or DBP 85–89, Stage 1 hypertensive SBP 140–159 or DBP 90–99, Stage 2 or 3 hypertensive SBP ≥160 or DBP ≥100. When a patient’s SBP and DBP fall in dif-
ferent categories, the higher category is used.
Tab. 3 Hypertension by age, sex and social status (prevalence and 95% CI), DEGS1, nunweighted=7,096
Age group 18–29 30–39 40–49 50–59 60–69 70–79 Total
Sex
Women 1.3 (0.7–2.6) 4.8 (2.8–8.2) 17.2 (14.2–20.7) 34.6 (30.5–38.4) 60.7 (55.7–65.5) 74.7 (70.2–78.8) 29.9 (28.1–31.9)
Men 8.4 (5.9–11.8) 11.4 (8.1–15.8) 26.2 (22.1–30.7) 41.7 (37.3–46.2) 58.8 (53.5–63.2) 73.6 (68.5–78.1) 33.3 (31.1–35.6)
Total 4.9 (3.6–6.7) 8.2 (6.2–10.8) 21.8 (19.0–24.8) 38.1 (35.0–41.4) 59.8 (56.1–63.3) 74.2 (70.6–77.5) 31.6 (30.1–33.2)
Social status
Women
Low 0.8 (0.2–3.6) 5.1 (1.2–19.0) 24.8 (15.6–36.9) 44.1 (33.0–55.9) 70.9 (59.3–80.3) 67.3 (57.5–75.8) 37.1 (32.8–41.6)
Middle 1.1 (0.4–2.8) 6.1 (3.3–11.0) 17.6 (13.9–22.0) 35.1 (30.0–40.5) 60.8 (54.3–66.9) 80.3 (75.2–84.6) 31.0 (28.7–33.5)
High 3.3 (1.0–10.2) 2.1 (0.7–6.0) 11.2 (6.8–18.0) 26.5 (18.3–36.9) 44.5 (34.2–55.3) 62.4 (48.9–74.1) 18.8 (15.3–22.7)
Men
Low 9.0 (3.7–20.7) 14.2 (6.3–29.1) 23.0 (15.0–33.7) 36.0 (25.7–47.7) 52.3 (39.7–64.5) 76.0 (62.8–85.5) 32.3 (27.1–37.9)
Middle 8.7 (6.0–12.4) 11.7 (7.5–17.9) 25.6 (20.4–31.6) 42.5 (36.6–48.7) 59.6 (52.3–66.5) 75.9 (69.7–81.2) 33.4 (30.8–36.1)
High 6.7 (2.2–18.2) 10.2 (5.1–19.1) 30.3 (22.9–38.8) 43.5 (34.9–52.6) 61.4 (53.3–68.4) 64.2 (52.2–74.6) 34.6 (31.0–38.3)
Total
Low 4.8 (2.1–10.9) 10.2 (5.0–19.8) 23.8 (17.6–31.5) 39.8 (32.0–48.2) 62.3 (53.5–70.4) 70.5 (62.2–77.6) 34.7 (31.3–38.4)
Middle 5.0 (3.6–7.0) 8.9 (6.2–12.5) 21.4 (18.0–25.3) 38.7 (34.9–42.7) 60.3 (55.4–64.9) 78.4 (74.5–81.8) 32.2 (30.3–34.1)
High 5.0 (2.2–11.0) 6.3 (3.5–11.0) 22.0 (17.1–27.8) 34.9 (27.9–42.6) 55.2 (48.5–61.8) 63.5 (54.8–71.5) 27.5 (24.9–30.3)
Hypertension SBP ≥140 or DBP ≥90 mmHg (mean of second and third DEGS1 measurements) or antihypertensive medication within last 7 days given that the person had 




ready known to be present in the vast ma-
jority of instances: among all age groups 
(18–79) on average one in four men and 
one in four women had known hyperten-
sion (26%, . Tab. 4). In addition, 4% of 
all women and 7% of all men had hyper-
tensive blood pressure in DEGS1 and thus 
may have undiagnosed hypertension. The 
proportion of hypertensive blood pres-
sure that first came to light in DEGS com-
pared to all instances of hypertension ac-
cording to the stated definition was 22% 
among men and 13% among women, al-
though there were marked age-related 
differences: in the younger age groups 
and within them, among men in par-
ticular, the proportion was higher and 
reached up to 76% among 18- to 29-year-
old men. Both known hypertension and 
hypertensive blood pressure without pre-
vious detection of high or elevated blood 
pressure were more prevalent in women 
with low social status compared to wom-
en with middle or high social status. Such 
social status differences were not found 
in men.
Discussion
DEGS1 provides information on the dis-
tribution of blood pressure in Germany 
and thus on the distribution of one of the 
most important preventable risk factors 
both for cardiovascular diseases and for 
overall mortality. Cardiovascular diseas-
es are still ranked highest in the mortality 
statistics in Germany [24]. However, the 
significant drop in stroke mortality and 
total cardiovascular mortality over the 
last 20 years [25] suggests there may have 
been positive developments in the most 
important modifiable risk factors, partic-
ularly blood pressure.
DEGS1 shows that hypertension af-
fects approximately 20 million adults in 
Germany and is therefore still a widely 
prevalent risk factor in the population. 
One in three adults in Germany has hy-
pertension (30% of women and 33% of 
men). The prevalence in young adults 
(18–29) is just under 5% but among 70–
79 year olds it reaches almost 75%. This 
hypertension prevalence data also in-
cludes one fifth undiagnosed hyperten-
sion as suggested by the DEGS1 measure-
ments (18% overall, 13% of women, 22% 
of men). A limitation of this finding is 
that undiagnosed hypertension can only 
be suspected from DEGS1 data, because 
although three blood pressure measure-
ments were made under standardised 
conditions in DEGS1 they were on one 
study day, which is not sufficient for a 
clinical diagnosis of hypertension. Con-
versely, these figures yield an estimated 
level of hypertension awareness of over 
80% in Germany, which is high when 
compared internationally [23, 26], but 
which is still unsatisfactory, particular-
ly among young men (less than a quar-
ter of men under 30 are aware of having 
hypertension). Despite certain differenc-
es in definition, the DEGS1 prevalence of 
known hypertension is consistent with 
results from the telephone survey GEDA 
2010 (German Health Update, Gesund-
heit in Deutschland aktuell 2010) con-
ducted by the Robert Koch Institute [27].
However, the actual level of blood 
pressure is more important than the di-
agnosis of hypertension. Approximate-
ly half of the participants with hyper-
tension were receiving treatment to con-
trol it, i.e. they were taking antihyperten-
sive medication and had blood pressure 
readings below the hypertension thresh-
old of 140/90 mmHg. Thus at 15% (men 
18%, women 13%), the population prev-
alence of adults with hypertensive blood 
pressure was only about half as high as the 
prevalence of hypertension. A detailed 
analysis of the DEGS1 data on the levels of 
awareness, treatment and control of hy-
pertension in Germany will be present-
ed in another publication. Only just over 
40% of adults had optimal blood pres-
sure, while 44% were at levels which are 
not yet hypertensive, but which are not 
optimal and which are associated with an 
increased risk of cardiovascular disease. 
Here too there were pronounced differ-
ences between men and women, with 
higher proportions of non-optimal blood 
pressure values among men than among 
women in almost all age groups. The gen-
der-related differences even out with in-
creasing age and among 70- to 79-year-
old women the prevalence of hyperten-
sion was even higher than among men of 
the same age.
Overall there is still a high potential 
for prevention. Estimates have shown that 
a combination of personal and non-per-
sonal health care interventions (e.g. hy-
pertension treatment and patient edu-
cation, programmes for reducing salt in 
food products, health education through 
Tab. 4 Known hypertension and hypertensive blood pressure (BP) with no previous diagnosis of hypertension (point prevalence and 95% CI), 
DEGS1, nunweighted=7,096
Age group 18-29 30-39 40-49 50-59 60-69 70-79 Total
Women
Known hypertension 0.9 (0.4–1.9) 3.3 (1.7–6.4) 13.6 (10.9–16.8) 28.0 (24.5–31.9) 54.9 (50.1–59.7) 67.8 (62.8–72.5) 25.9 (24.2–27.6)
Hypertensive BP 0.4 (0.1–1.7) 1.5 (0.6–3.8) 3.5 (2.1–5.7) 6.3 (4.3–9.2) 5.7 (3.7–8.5) 6.8 (4.7–10.0) 4.0 (3.2–4.9)
Men
Known hypertension 1.9 (1.0–3.7) 7.5 (4.8–11.5) 17.5 (14.0–21.6) 32.7 (28.5–37.2) 51.8 (46.6–56.9) 64.9 (59.2–70.2) 26.0 (24.6–27.3)
Hypertensive BP 6.2 (4.0–9.5) 3.5 (1.8–6.7) 8.5 (6.0–12.0) 9.0 (6.8–11.7) 7.0 (4.8–9.9) 8.5 (5.5–13.0) 7.2 (6.1–8.4)
Total
Known hypertension 1.4 (0.8–2.3) 5.4 (3.8–7.8) 15.6 (13.3–18.2) 30.4 (27.6–33.3) 53.4 (49.8–57.0) 66.5 (62.8–70.0) 25.9 (24.6–27.3)
Hypertensive BP 3.4 (2.2–5.1) 2.5 (1.5–4.3) 6.1 (4.6–8.0) 7.7 (6.1–9.6) 6.3 (4.8–8.2) 7.6 (5.8–10.0) 5.6 (4.9–6.3)
Known hypertension hypertensive blood pressure (BP) (SBP ≥140 or DBP ≥90 mmHg) or antihypertensive medication in the past 7 days, in participants who reported that 
they had been told previously by a doctor that they have high or elevated blood pressure. Hypertensive BP hypertensive BP in DEGS1 (SBP ≥140 or DBP ≥90 mmHg, using 
the mean of the second and third DEGS1 measurements) in participants who denied detection of high or elevated blood pressure by a doctor in the past.
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the media) is cost effective and could low-
er the global incidence of cardiovascular 
diseases by as much as 50% [28].
While measuring blood pressure is 
one of the most common and simple ex-
aminations in medicine, epidemiological 
data that permit a valid assessment of the 
blood pressure distribution in a popula-
tion are rare and costly. In clinical prac-
tice blood pressure is evaluated accord-
ing to measurements made on several 
days or according to 24-h blood pressure 
measurements and differences in blood 
pressure of only a few mmHg are of limit-
ed significance. In epidemiological stud-
ies, however, which deal with whole pop-
ulations, the effects of a few mmHg ac-
cumulate and if they are population-wide 
they lead to large changes in cardiovascu-
lar morbidity and mortality. The preva-
lence of hypertension can also change to 
a surprising degree, as many people have 
blood pressure levels that are only mar-
ginally above or below the hypertension 
threshold. Thus in epidemiological stud-
ies great efforts are made to standardise 
and optimise measurements to avoid sys-
tematic measurement errors of even just 
a few mmHg.
This report presents up-to-date in-
formation on blood pressure in Germa-
ny from 2008–2011 based on DEGS1 data. 
The blood pressure measurement meth-
odology used in DEGS1 has been im-
proved compared to that used in GN-
HIES98, such that comparisons will be 
possible soon, once a procedure for cali-
brating the GNHIES98 data has been de-
veloped. The changes relate to the switch 
from the auscultatory method to the os-
cillometric method of measurement to 
avoid examiner bias and also relate to im-
provements in the allocation of pressure 
cuffs in relation to upper arm circumfer-
ence. The oscillometric blood pressure 
device used in DEGS1 was selected based 
on published validation studies that show 
a high degree of agreement with the gold 
standard sphygmomanometer used in 
GNHIES98 [18, 19, 20].
Along with the change of blood pres-
sure measurement device between GN-
HIES98 and DEGS1 there was also a 
change in the cuff bladder sizes offered by 
manufacturers. This is the consequence 
of a complex discussion that has gone on 
for several decades about optimal blad-
der size and its relation to arm circum-
ference [29]. Since undercuffing (blad-
der too small) leads to overestimation of 
blood pressure and overcuffing (bladder 
too large) to underestimation of blood 
pressure different pressure cuffs should 
be available not only for children but also 
for adults [30]. This has not become es-
tablished in clinical practice yet. In epi-
demiological studies however, it is stan-
dard practice to have at least three cuffs 
for adults, although there is still no inter-
national consensus as to the optimal re-
lationship between bladder size and up-
per arm circumference [31, 32]. The mea-
surement protocol used in GNHIES98 
including the three cuff sizes was based 
on the WHO MONICA protocol, which 
in its original form at the beginning of 
the MONICA Project in the early 1980s 
was a reference for highly standardised 
and valid blood pressure measurement 
[33]. However, while the GNHIES98 cuff 
bladder dimensions and the instructions 
to use them for specific ranges of up-
per arm circumferences are still formal-
ly compatible with European (and in par-
ticular with British) guidelines on blood 
pressure measurement [34], there is now 
convincing evidence that blood pressure 
measurement is more valid with the cuffs 
used in DEGS and that cuff-related blood 
pressure differences can, at least in epi-
demiological studies, reach a relevant or-
der of magnitude [35, 36, 37, 38, 39]. Be-
fore comparing the data from GNHIES98 
and DEGS, the changes in measurement 
methods (device and cuff changes) were 
evaluated in a pilot study. This study 
confirmed the need to calibrate the GN-
HIES98 data to permit comparison with 
DEGS1. A calibration procedure is there-
fore currently being developed on the ba-
sis of comprehensive comparative mea-
surements, so that an analysis of tempo-
ral trends will soon be possible.
Overall the DEGS1 results confirm the 
ongoing public health relevance of high 
blood pressure in Germany. Accord-
ing to a new WHO report, high blood 
pressure became the greatest health risk 
worldwide in 2010 [3]. High blood pres-
sure is still highly prevalent in Germany 
and there is still a large potential for pre-
vention, not only through pharmacolog-
ic treatment but through a population-
wide shift towards a healthier lifestyle and 
a health-promoting living environment.
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